PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 48 filers reported holding PROTARA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $100 | -50.0% | 60,100 | -28.1% | 0.00% | – |
| Q2 2023 | $200 | +8.7% | 83,600 | +41.9% | 0.00% | – |
| Q1 2023 | $184 | +2.2% | 58,906 | -12.1% | 0.00% | – |
| Q4 2022 | $180 | -99.9% | 67,000 | -15.4% | 0.00% | – |
| Q3 2022 | $234,000 | +47.2% | 79,200 | +46.1% | 0.00% | – |
| Q2 2022 | $159,000 | -17.2% | 54,200 | +44.1% | 0.00% | – |
| Q1 2022 | $192,000 | -56.1% | 37,600 | -42.0% | 0.00% | -100.0% |
| Q4 2021 | $437,000 | -45.5% | 64,800 | -44.1% | 0.00% | 0.0% |
| Q3 2021 | $802,000 | +60.1% | 115,900 | +125.4% | 0.00% | 0.0% |
| Q2 2021 | $501,000 | +1.4% | 51,427 | +63.8% | 0.00% | 0.0% |
| Q1 2021 | $494,000 | +19.3% | 31,400 | +83.5% | 0.00% | – |
| Q4 2020 | $414,000 | -34.9% | 17,110 | -54.7% | 0.00% | -100.0% |
| Q3 2020 | $636,000 | -27.6% | 37,786 | +26.0% | 0.00% | 0.0% |
| Q2 2020 | $879,000 | – | 29,986 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,692,594 | $4,496,632 | 1.46% |
| Privium Fund Management (UK) Ltd | 119,730 | $201,146 | 0.16% |
| Ikarian Capital, LLC | 188,664 | $315,069 | 0.04% |
| Orbimed Advisors | 772,584 | $1,290,215 | 0.03% |
| Boxer Capital, LLC | 209,227 | $349,409 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 64,000 | $106,880 | 0.00% |
| Baker Brothers Advisors | 199,671 | $333,451 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 18,864 | $31,503 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 27,345 | $45,666 | 0.00% |
| OSAIC HOLDINGS, INC. | 100 | $167 | 0.00% |